APA

Buzdar A. U., Singletary S. E., Theriault R. L., Booser D. J., Valero V., Ibrahim N., Smith T. L., Asmar L., Frye D., Manuel N., Kau S. W., McNeese M., Strom E., Hunt K., Ames F. & Hortobagyi G. N. (20000118). Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Buzdar A U, Singletary S E, Theriault R L, Booser D J, Valero V, Ibrahim N, Smith T L, Asmar L, Frye D, Manuel N, Kau S W, McNeese M, Strom E, Hunt K, Ames F and Hortobagyi G N. 20000118. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Buzdar A. U., Singletary S. E., Theriault R. L., Booser D. J., Valero V., Ibrahim N., Smith T. L., Asmar L., Frye D., Manuel N., Kau S. W., McNeese M., Strom E., Hunt K., Ames F. and Hortobagyi G. N. (20000118). Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Buzdar A U, Singletary S E, Theriault R L, Booser D J, Valero V, Ibrahim N, Smith T L, Asmar L, Frye D, Manuel N, Kau S W, McNeese M, Strom E, Hunt K, Ames F and Hortobagyi G N. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20000118.